gamma-glutamine-4-nitroanilide and carfilzomib

gamma-glutamine-4-nitroanilide has been researched along with carfilzomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cwiek, A; Kaminska, K; Kedzierska, H; Kosnik, A; Marusiak, AA; Mehlich, D; Nowis, D; Prelowska, MK; Ugurlu, MT	1

Other Studies

1 other study(ies) available for gamma-glutamine-4-nitroanilide and carfilzomib

Article	Year
Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors. Cancer letters, 2021, 06-01, Volume: 507 Topics: Amino Acid Transport System ASC; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Stress; Glutamine; Humans; Minor Histocompatibility Antigens; Multiple Myeloma; Oligopeptides; Oxidative Stress; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Unfolded Protein Response	2021

Article

Year

Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.

Cancer letters, 2021, 06-01, Volume: 507

Topics: Amino Acid Transport System ASC; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Stress; Glutamine; Humans; Minor Histocompatibility Antigens; Multiple Myeloma; Oligopeptides; Oxidative Stress; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Unfolded Protein Response

2021